<DOC>
	<DOCNO>NCT00186914</DOCNO>
	<brief_summary>Osteodysplasia poorly form bone , `` brittle bone '' genetic disease know proven treatment . Some form osteodysplasia may cause severe disability even death . Eligible patient limited child Osteodysplasia undergone previous allogeneic bone marrow transplant St. Jude . The study intervention involve infusion specify number ex vivo expand stromal cell obtain bone marrow donor receive primary transplant procedure . These bone marrow stromal cell become bone-forming cell , call osteoblast . Participants receive 2 infusion ex vivo expand , gene mark cell less 6 month bone marrow transplantation . The second cell infusion occur 14 21 day first infusion absence toxicity . The goal study evaluate safety toxicity infusion .</brief_summary>
	<brief_title>Stromal Therapy Osteodysplasia After Allogeneic Bone Marrow Transplantation</brief_title>
	<detailed_description>- To determine whether ex vivo expand , gene mark marrow stromal cell engraft recipient 's bone , bone marrow , and/or skin . - To begin investigate whether high proliferative mesenchymal progenitor cell expand ex vivo retain progenitor potential vivo . - To begin investigate whether ex vivo expand bone marrow stromal cell ameliorate skeletal dysplasia associate various genetic disorder .</detailed_description>
	<criteria>Patients appropriate genetic disorder allogeneic bone marrow transplant currently maintain complete mixed hematopoietic chimerism Patient must &lt; equal 18Kg Presence infection Presence GVHD ( graft versus host disease ) need prophylaxis Concurrent participation investigational study could potentially confound interpretation safety parameter investigate study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Bone marrow transplant</keyword>
	<keyword>bone marrow stromal cell</keyword>
	<keyword>allogeneic transplant</keyword>
	<keyword>Osteodysplasia</keyword>
	<keyword>Osteogenesis imperfecta</keyword>
	<keyword>Gene mark</keyword>
	<keyword>Stromal cell</keyword>
</DOC>